The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.


Updates from The Motley Fool

Latest updates on ICON from Fool.com.


Stock Performance

ICLR vs. S&P 500 | 2 Year Performance
View Interactive ICLR Charts
Sponsored by

Key Data Points

Primary metrics and data points about ICON.
Current Price: $76.48
Prev Close: $76.48
Open: $75.89
Bid: $73.75
Ask: $83.33
Day's Range: $74.93 - $77.02
52wk Range: $62.31 - $79.61
Volume: 331,137
Avg Vol 311,914
Market Cap: $4.38B
P/E (ttm): 19.26
EPS (ttm): $3.97
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ICON.
CAPS Rating 5 out of 5
 
353 Outperform
11 Underperform
CAPS All Stars
 
82 Outperform
4 Underperform

How do you think ICON will perform against the market?



You pick for ICON is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ciaran Murray, CEO

65% Approve

Based on 142 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ICON.

The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT